| 发明名称 |
Fusion protein having enhanced in vivo activity of erythropoietin |
| 摘要 |
<p>A fusion protein (I), where a carboxy terminal peptide (CTP) of thrombopoietin (TPO) is fused with the carboxy terminal of human erythropoietin (EPO), is new. Independent claims are also included for the following: (1) nucleic acid (II) encoding (I); and (2) preparing (I). - ACTIVITY : Antianemic. No biological data is given. - MECHANISM OF ACTION : Stimulator of production and differentiation of red blood cells.</p> |
| 申请公布号 |
EP1319712(B1) |
申请公布日期 |
2010.03.10 |
| 申请号 |
EP20020016953 |
申请日期 |
2002.08.01 |
| 申请人 |
CJ CHEILJEDANG CORP. |
发明人 |
LEE, DONG-EOK;OH, MYUNG-SUK;CHUNG, BO-SUP;PARK, JI-SOOK;KIM, KI-WAN |
| 分类号 |
C12N15/02;C12N15/12;A61K38/18;A61P7/06;C07K7/08;C07K14/475;C07K14/505;C07K14/52;C07K19/00;C12N15/62;C12P21/02 |
主分类号 |
C12N15/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
